The AP-1 Binding Sites Located in the pol Gene Intragenic Regulatory Region of HIV-1 Are Important for Viral Replication
暂无分享,去创建一个
A. Bergamaschi | A. Burny | C. Van Lint | Laurence Colin | C. Vanhulle | O. Rohr | G. Herbein | G. Pancino | S. de Walque | V. Martinelli | Allan Guiguen | A. David | T. Cherrier | Benoit Van Driessche | Nathalie Vandenhoudt
[1] C. Van Lint,et al. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies , 2009, Retrovirology.
[2] L. Kenner,et al. Translational regulation mechanisms of AP-1 proteins. , 2009, Mutation research.
[3] R. Hipskind,et al. SUMOylation Regulates the Transcriptional Activity of JunB in T Lymphocytes1 , 2008, The Journal of Immunology.
[4] Shou-Jiang Gao,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. , 2008, Virology.
[5] David G. Castner,et al. Microplate-based chromatin immunoprecipitation method, Matrix ChIP: a platform to study signaling of complex genomic events , 2008, Nucleic acids research.
[6] F. Dequiedt,et al. Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing , 2007, The EMBO journal.
[7] M. Fresno,et al. Human immunodeficiency virus type 1 Tat increases cooperation between AP-1 and NFAT transcription factors in T cells. , 2006, The Journal of general virology.
[8] R. Sarid,et al. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. , 2006, The Journal of general virology.
[9] K. Jeang,et al. Role for Akt/Protein Kinase B and Activator Protein-1 in Cellular Proliferation Induced by the Human T-cell Leukemia Virus Type 1 Tax Oncoprotein* , 2006, Journal of Biological Chemistry.
[10] P. Wei,et al. Expression of adipose differentiation-related protein (ADRP) is conjointly regulated by PU.1 and AP-1 in macrophages. , 2005, Journal of biochemistry.
[11] A. Burny,et al. Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity , 2005, Nucleic acids research.
[12] R. Hipskind,et al. Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation , 2005, Molecular and Cellular Biology.
[13] B. Prusty,et al. Constitutive activation of transcription factor AP‐1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP‐1 activity in HeLa cells by curcumin , 2005, International journal of cancer.
[14] P. Angel,et al. AP-1 subunits: quarrel and harmony among siblings , 2004, Journal of Cell Science.
[15] F. Rivas,et al. Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes. , 2003, Biochemical and biophysical research communications.
[16] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[17] M. Piechaczyk,et al. The HBZ Factor of Human T-cell Leukemia Virus Type I Dimerizes with Transcription Factors JunB and c-Jun and Modulates Their Transcriptional Activity* , 2003, Journal of Biological Chemistry.
[18] F. Barré-Sinoussi,et al. Fcγ Receptor-Mediated Suppression of Human Immunodeficiency Virus Type 1 Replication in Primary Human Macrophages , 2003, Journal of Virology.
[19] N. Moolla,et al. Regulatory elements of hepatitis B virus transcription , 2002, Journal of viral hepatitis.
[20] V. Kiermer,et al. Upstream Stimulatory Factors Binding to an E Box Motif in the R Region of the Bovine Leukemia Virus Long Terminal Repeat Stimulates Viral Gene Expression* , 2002, The Journal of Biological Chemistry.
[21] M. Linial,et al. Cell-Type-Specific Regulation of the Two Foamy Virus Promoters , 2001, Journal of Virology.
[22] M. Giacca,et al. Multiple Modes of Transcriptional Regulation by the HIV‐1 Tat Transactivator , 2001, IUBMB life.
[23] T. Mizutani,et al. Identification of SWI·SNF Complex Subunit BAF60a as a Determinant of the Transactivation Potential of Fos/Jun Dimers* , 2001, The Journal of Biological Chemistry.
[24] F. Kirchhoff,et al. Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway , 2000, The Journal of Biological Chemistry.
[25] D. Gabuzda,et al. ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-κB* , 1999, The Journal of Biological Chemistry.
[26] Hii,et al. Direct evidence that ERK regulates the production/secretion of interleukin‐2 in PHA/PMA‐stimulated T lymphocytes , 1999, Immunology.
[27] Daniel G. Tenen,et al. c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor* , 1999, The Journal of Biological Chemistry.
[28] J. Clements,et al. Targeting of the Visna Virus Tat Protein to AP-1 Sites: Interactions with the bZIP Domains of Fos and Jun In Vitro and In Vivo , 1999, Journal of Virology.
[29] K. Jeang,et al. Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat , 1998, Journal of Virology.
[30] B. Hoffman,et al. AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. , 1998, International journal of oncology.
[31] C. Vinson,et al. A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Van Lint,et al. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity , 1997, Journal of virology.
[33] M. Olive,et al. A Dominant Negative to Activation Protein-1 (AP1) That Abolishes DNA Binding and Inhibits Oncogenesis* , 1997, The Journal of Biological Chemistry.
[34] C. Van Lint,et al. Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.
[35] K. Tomonaga,et al. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats , 1996, Journal of virology.
[36] D. Latchman,et al. Functional interaction between the HIV-1 Tat transactivator and the inhibitory domain of the Oct-2 cellular transcription factor , 1996, AIDS.
[37] M. Giacca,et al. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[38] D. Ganem,et al. Activation of N-myc2 gene expression by cis-acting elements of oncogenic hepadnaviral genomes: key role of enhancer II. , 1996, Virology.
[39] D. Aunis,et al. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells , 1995, Journal of virology.
[40] R. Gaynor,et al. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants , 1994, Journal of virology.
[41] A. Burny,et al. A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1 , 1994, Journal of virology.
[42] W. Greene,et al. Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.
[43] C. Van Lint,et al. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. , 1993, The EMBO journal.
[44] R. Davis,et al. The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.
[45] I. Screpanti,et al. Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription. , 1993, Molecular endocrinology.
[46] J. Alwine,et al. Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat , 1993, Journal of virology.
[47] P. Howley,et al. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes , 1992, Journal of virology.
[48] E. Verdin. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of integrated human immunodeficiency virus type 1 , 1991, Journal of virology.
[49] A. Burny,et al. The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites , 1991, Journal of virology.
[50] V. ter meulen,et al. Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat , 1991, Journal of virology.
[51] J. Alwine,et al. Analysis of the human immunodeficiency virus long terminal repeat by in vitro transcription competition and linker scanning mutagenesis. , 1991, Gene expression.
[52] Tony Hunter,et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.
[53] A. Burny,et al. Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[54] R. Müller,et al. Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. , 1989, The EMBO journal.
[55] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Malim,et al. Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes , 1988, Nature.
[57] R. Tjian,et al. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.
[58] R. Tjian,et al. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 , 1987, Nature.
[59] R. Warnke,et al. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. , 1984, Cancer research.
[60] Arthur Weiss,et al. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. , 1984, Journal of immunology.
[61] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[62] K. Bomsztyk,et al. Protocol for the fast chromatin immunoprecipitation (ChIP) method , 2006, Nature Protocols.
[63] H. Herschman. Primary response genes induced by growth factors and tumor promoters. , 1991, Annual review of biochemistry.